Viagra's active ingredient may have a surprising role beyond treating erectile dysfunction, with new research suggesting it could interfere with the biological processes that allow cancer cells to spread to other parts of the body.
The study by scientists at the Weizmann Institute of Science found that sildenafil may restrict cancer metastasis by disrupting how cancer cells access and use cholesterol. The findings raise the possibility that an existing drug could eventually be repurposed as part of strategies aimed at preventing cancer from spreading, although the research is still far from proving that Viagra can treat cancer in people.
